Mumbai
08048034404
+918506873687

India's first DM Hepatologist of Maharashtra — available worldwide

https://claude.ai/public/artifacts/2cf257e4-8a4c-4e2a-b762-0f045818f464

India's leading liver
specialist. Available
in your timezone.

Whether you're in London, Dubai, Toronto, or Sydney — and your liver diagnosis is complex, incomplete, or demands a second authority — Dr. Chetan Kalal delivers subspecialty hepatology that most Western waiting lists can't match for timeline or volume.

About Dr. Chetan Kalal

India's first DM Hepatologist of Maharashtra — available worldwide

Dr. Chetan Kalal is India's leading hepatologist and liver transplant specialist, and the first DM-qualified Hepatologist in Maharashtra. He holds DM (Hepatology), MD (Medicine), and MRCP (UK) — the highest hepatology subspecialty qualification in India. Practising in Mumbai, he provides virtual consultations, expert second opinions, and liver transplant evaluation for NRI and international patients in the United Kingdom, United States, UAE, Dubai, Singapore, Australia, New Zealand, Canada, and across Asia, Europe, and the Middle East. His clinical focus includes advanced liver disease, liver cirrhosis, hepatocellular carcinoma, portal hypertension, ACLF, autoimmune liver diseases, viral hepatitis, and living donor liver transplantation (LDLT).

Why India for Liver Care

What India's liver medicine actually offers that most Western systems don't

This is not a pitch. It is a clinical reality that NRI families navigating the UK's NHS waiting system, the US's insurance gatekeeping, or the UAE's limited transplant infrastructure encounter directly.

India's high-volume liver centres — particularly those with dedicated DM Hepatologists — see disease presentations that most Western centres encounter a fraction as frequently. That volume translates into diagnostic pattern recognition and procedural experience that isn't replicable through guideline reading alone.

⏱️

LDLT removes the waiting list

India's living donor pathway means a compatible family member can donate — no deceased-donor queue, no MELD rank-waiting. For patients with progressive disease, this is often the only timely option.

🔬

South Asian disease phenotypes — managed here

Lean NAFLD in Indians, HBV reactivation patterns specific to the subcontinent, Wilson's disease in younger patients — these are daily clinical territory in Mumbai, not occasional case reports.

💷

Cost — substantially lower, quality not

Subspecialty consultation, liver biopsy interpretation, and transplant workup in India cost a fraction of equivalent procedures in the UK, USA, or UAE — without compromising clinical standards.

🤝

Coordinated with your local care team

Dr. Kalal's written clinical direction reports are structured for direct handover to your UK GP, US hepatologist, or UAE physician — ensuring continuity rather than fragmentation.

https://claude.ai/public/artifacts/2cf257e4-8a4c-4e2a-b762-0f045818f464



   

 2026-06-27T05:23:27

Other Pages

View all pages